PT -期刊文章盟Federica Azzolini AU - Matteo Grammatico盟乔凡娜卡卢奇AU -卢西亚Goanta AU -普Dallagiacoma盟安娜玛丽亚丽塔Repice AU -贝内黛塔Forci盟弗朗西斯卡素质AU -莱昂纳多马奇盟Enrico Fainardi AU -卢卡Massacesi TI - MS患者低中央静脉的信号频率可以通过天赋*确定MRi序列(p5.2 - 041) DP - 2019年4月09年TA -神经病学第六PG - p5.2 - 041 - 92 IP - 15补充4099 - //www.ez-admanager.com/content/92/15_supplement/p5.2 041. - 041.短4100 - //www.ez-admanager.com/content/92/15_supplement/p5.2 - 首页-全所以Neurology2019 4月09年;92 AB -目的:评估的分析是否中央静脉(CVS)和“50%规则”可以识别子组的多发性硬化(MS)患者。背景:CVS可以区分女士和其他疾病的大脑白质的女士可能更好的解释或模仿别人的人偏头痛,小血管疾病,动谱系障碍和大脑参与系统性自身免疫性疾病。CVS频率的阈值,允许排除女士一直到目前为止建立在50%(“50%规则”)。设计/方法:明确的患者(根据麦当劳标准诊断)女士和女士患者临床实验室和MRi标记更好的解释,但不满足其他疾病的诊断标准(MS-plus),也包括在内。病人接受一个MRi扫描包括一个天赋和一个T2 *序列,statyfied根据50%规则。两组病人的临床过程评估。结果:定的CVS中值频率的病人(n = 30)女士和MS-plus患者(n = 55) 91%(68 - 100%)范围内,和分别为55%(11 - 95%范围)。MS-plus病人,28日会见了“50%规则”,显示22%的平均频率(11 - 40%范围),而其他27个MS-plus CVS的频率范围内的定女士没有其他核磁共振参数与每组隔离。疾病的自然历史的分析,目前建议更良性的疾病在MS-plus病人完成50%规则与那些不尊重。结论:一群MS-plus CVS患者低频率(规则完成50%)可以被一个常规MRi扫描。 The natural history of the disease in this group seems more benign than in definite MS and in MS-plus not fulfilling the 50% rule, suggesting either that these patients have a benign MS form or that are not MS.Disclosure: Dr. Azzolini has nothing to disclose. Dr. Grammatico has nothing to disclose. Dr. Carlucci has nothing to disclose. Dr. Goanta has nothing to disclose. Dr. Dallagiacoma has nothing to disclose. Dr. Repice has nothing to disclose. Dr. Forci has nothing to disclose. Dr. Dipasquale has nothing to disclose. Dr. Marchi has nothing to disclose. Dr. Fainardi has nothing to disclose. Dr. Massacesi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Merck-Serono, Mylan, Novartis, Roche, and Sanofi. Dr. Massacesi has received research support from Biogen, Merck-Serono, Mylan, Novartis, Roche, and Sanofi.

map